Two-Days National Conference on “Nanomedicine 2.0 CRISPR-Edited Nanoparticles for Targeted Cancer Therapy”

A Two-Day National Conference on “Nanomedicine 2.0 CRISPR-Edited Nanoparticles for Targeted Cancer Therapy” was organized by Saraswati College of Pharmacy, Gharuan, Mohali, Punjab on 11th and 12th September 2026. The main objective of the conference was to provide a platform for scientific interaction, knowledge sharing, and academic discussion on emerging developments in nanomedicine, CRISPR-edited nanoparticles, and targeted cancer therapy. The programme included inaugural proceedings, keynote addresses, plenary lectures, expert sessions, poster presentations, cultural activities, and a valedictory session. The conference commenced on 11th September 2026 with registration and breakfast, followed by the inaugural session. The inaugural programme included the introduction of the programme, ceremonial lamp lighting, Saraswati Vandana, welcome and keynote address by Prof. (Dr.) Pradeep Goyal, Principal (Pharmacy), followed by the keynote address by Prof. Ashish Vyas, Campus Director, Saraswati Group of Colleges. The programme further included addresses by Dr. S. S. Sharma, Professor and HOD, NIPER and Vice President of the Indian Pharmacological Society, and Dr. Naveen Gupta, Chairperson, Department of Microbiology, Panjab University, followed by felicitation of the guests and group photograph. The scientific sessions commenced with the first plenary lecture by Dr. Siddarth Tiwari, Scientist F, BRIC-NABI, Department of Biotechnology, Mohali, Punjab. The afternoon session included the second expert session by Dr. Harish Dureja, Dean Research, MDU Rohtak, followed by a cultural event and the third expert session by Dr. Tapan Behal, Professor and HOD, Amity University Mohali. A Poster Presentation was also conducted, providing participants with an opportunity for scientific communication and academic interaction. On 12th September 2026, the second day began with breakfast followed by the plenary session. The programme included the introduction and welcome of the guest, lamp lighting, and a recap of Day 1. The fourth expert session was delivered by Dr. Jiban Jyoti Panda, Scientist E, INST, Mohali, followed by guest felicitation. The fifth expert session was conducted online by Dr. Longathan Kartik, Founder, Arqgene & Sasi Nutraceuticals, Tamil Nadu, followed by a cultural event and the Valedictory Session. The conference concluded with remarks and a Vote of Thanks by Dr. Kirti Sharma, Head and IQAC Associate Director, Department of Pharmacy. The conference provided an interactive academic platform for students, faculty members, researchers, academicians, and invited experts to engage with contemporary topics related to nanomedicine and targeted cancer therapy. The expert and plenary sessions provided exposure to scientific perspectives, while the poster presentations encouraged academic participation and scientific communication. Overall, the Two-Day National Conference was successfully conducted and provided valuable opportunities for knowledge sharing, scientific interaction, research exposure, and academic engagement. The participation of invited experts and the inclusion of plenary lectures, expert sessions, poster presentations, cultural activities, and the valedictory programme made the conference an informative and academically engaging event.

• To provide a platform for scientific interaction and knowledge sharing on emerging developments in nanomedicine and CRISPR-edited nanoparticles.
• To enhance understanding of the application of nanotechnology and CRISPR-based approaches in targeted cancer therapy.
• To provide students and faculty members with an opportunity to interact with scientists, academicians, researchers and subject experts.
• To familiarize participants with recent research developments and emerging approaches in targeted cancer therapy through plenary and expert sessions.
• To encourage scientific communication and academic participation through poster presentations.
• To promote interaction and engagement among participants through expert sessions, cultural activities and academic discussions.
• To provide a platform for academic exchange and exposure to contemporary research perspectives in the field of nanomedicine and cancer therapy.
• To encourage students and faculty members to actively participate in research-oriented academic activities.

The Two-Day National Conference on “Nanomedicine 2.0 CRISPR-Edited Nanoparticles for Targeted Cancer Therapy” provided students and faculty members with an opportunity to gain exposure to emerging developments in nanomedicine, CRISPR-edited nanoparticles, and targeted cancer therapy. The expert and plenary sessions delivered by invited scientists and academicians provided valuable academic and research-oriented insights into the field. The conference also provided a platform for scientific interaction, knowledge sharing and academic discussion among participants. The poster presentations encouraged scientific communication and academic participation, while the cultural activities and interaction with invited experts contributed to overall engagement during the programme. Overall, the conference enhanced participants' awareness of contemporary research areas, scientific interaction, academic exposure and understanding of emerging approaches in nanomedicine and targeted cancer therapy, thereby contributing to their academic and research-oriented development.